drugset / Trial / NCT01432574

Study of Gardasil in Mid-Adult Males (MAM)

NCT01432574

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to test the effectiveness of the research study vaccine, Gardasil, in men ages 27-45 who have completed 4 years of observation in The Human Papillomavirus \[HPV\] infection in men (HIM) Study.

Timeline

Start
2013-02-19
Primary completion
2014-05-23
Completion
2020-11-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil Vaccine